# Clinical Performance of SE-SPTM-PCR in Detecting Hcmv-miR-UL22A-5p After Hematopoietic Stem Cell Transplantation

> **NCT07181330** · — · COMPLETED · sponsor: **Ting YANG** · enrollment: 60 (actual)

## Conditions studied

- Cytomegalovirus Infections
- Hematopoietic Stem Cell Transplantation (HSCT)
- CMV Reactivation
- ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

## Interventions

- **DIAGNOSTIC_TEST:** SE-SPTM-PCR microRNA assay

## Key facts

- **NCT ID:** NCT07181330
- **Lead sponsor:** Ting YANG
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-06
- **Primary completion:** 2021-05-06
- **Final completion:** 2025-06-18
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07181330

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07181330, "Clinical Performance of SE-SPTM-PCR in Detecting Hcmv-miR-UL22A-5p After Hematopoietic Stem Cell Transplantation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07181330. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*